Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.27B
-
Number of holders
-
2155
-
Total 13F shares, excl. options
-
992M
-
Shares change
-
-3.36M
-
Total reported value, excl. options
-
$68.6B
-
Value change
-
-$273M
-
Put/Call ratio
-
0.98
-
Number of buys
-
1012
-
Number of sells
-
-1068
-
Price
-
$69.13
Significant Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q2 2023
2,434 filings reported holding CVS - CVS HEALTH Corp - Common Stock as of Q2 2023.
CVS HEALTH Corp - Common Stock (CVS) has 2,155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 992M shares
of 1.27B outstanding shares and own 78.16% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (117M shares), BlackRock Inc. (93.7M shares), STATE STREET CORP (55.9M shares), MORGAN STANLEY (33.3M shares), Capital World Investors (30.5M shares), GEODE CAPITAL MANAGEMENT, LLC (23.3M shares), FMR LLC (21.3M shares), Invesco Ltd. (17M shares), BANK OF AMERICA CORP /DE/ (16.6M shares), and Dodge & Cox (16M shares).
This table shows the top 2155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.